Old Mission Capital’s Celgene Corp CELG Stock Holding History

Old Mission Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,941	Closed	-$203K	–	593
2017 Q4	$203K	Buy	+1,941	New	+$219K	0.01%	353

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Old Mission Capital's CELG Position: Q1 2018 in Review

Old Mission Capital sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 1,941 shares — an estimated $203K sold.

Old Mission Capital first reported a position in CELG in Q4 2017 and held it in 1 quarter. The position peaked at $203K in Q4 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Old Mission Capital reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Old Mission Capital sold 1,941 Celgene Corp shares in Q1 2018, an estimated $203K.
Old Mission Capital first reported a position in Celgene Corp in Q4 2017 and held it in 1 quarter.
Old Mission Capital's Celgene Corp position peaked at $203K in Q4 2017.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Old Mission Capital's 13F filing for Q1 2018, filed 15 May 2018.